LS CancerDiag selected for EIT Health Bridgehead programme!

LS CancerDiag selected for EIT Health Bridgehead programme!

We are delighted to announce that LS CancerDiag has been selected as a participant to the EIT Health Bridghead Global programme!

The Bridgehead programme provides European start-ups and scale-ups with individualised support in growing their validated businesses beyond their home markets. During this process, start-ups are guided by members of EIT Health’s vetted European network of top-notch accelerators, who open the right doors to establish and grow cross-border business.

LS CancerDiag is thirlled to be joining this programme! The company is convinced that this Accelerator programme will provide another important piece to the international expansion efforts in bringing DiagMMR® to hospitals worldwide. Out of the various possible markets, the company has identified priorities, but is also looking forward to learn from the Global CATs (see below), what pros and cons each market holds and decide where to put our efforts.

You can find the announcement on the EIT Health news website

We are also pleased to share that LS CancerDiag was also selected for the 2nd stage of the Scandinavian (regional) selection of the European Health Catapult (a pitch competition). Another EIT Health Accelerator programme, however a company can only participate either in Bridgehead or in the Catapult programme during the same calendar year. And we have decided to prioritise Bridgehead in this opportunity.

About Bridgehead Global

Bridgehead Global is an internationalisation programme to facilitate European health start-ups in scaling out beyond Europe. The programme’s aim is to prepare the ground for international expansion and to help start-ups achieve their first tangible business results in non-European markets. The programme follows an individual and needs-based approach by matching promising start-ups and SMEs to suitable clusters, accelerators and incubators (Global CATalysers, or Global CATs) that are based in Europe and cooperate with their own network of global partners beyond Europe.

EIT Health provides funding up to €40 000 for SMEs to work with a Global CAT who will guide the start-up and facilitate their preparation and readiness to travel to the location of their choice within EIT Health’s network of collaborators beyond-Europe, including the US, Canada, Israel, China and Japan, among others. The participants are individually supported in entering new markets with knowledge about specific countries’ healthcare systems, regulatory environments, key stakeholders and competitors. Global CATs offer Bridgehead Global start-ups structured access to vibrant eco-systems, with connections to industries, corporations, venture capital, entrepreneurs, experts, specialists and mentors.

About EIT Health

EIT Health was established in 2015, as a ‘knowledge and innovation community’ (KIC) of the European Institute of Innovation and Technology (EIT). The EIT is made up of various KICs who each focus on a different sector, or area, of innovation – in this case, that is health and aging.

Invest today!

LS CancerDiag has launched a funding round in collaboration with Springvest

The company aims to raise €5.4M in capital to support the expansion into the United States and introduce DiagMMR® to the largest health care market in the world.